Lipson Sheds Light on the Evolving Role of ctDNA in the Realm of Melanoma
December 23rd 2021
Evan J. Lipson, MD, discusses the role of ctDNA in the neoadjuvant, adjuvant, and metastatic settings in the realm of melanoma, remaining questions with this marker, and future directions to optimize its use in this disease.